Patient Education: Off-Label Medications in Cancer Care

Exploring Unconventional Paths:

Doctor-patient Dialogues On Off-label Medications In Cancer Care

Paul Zhang, M.D., Ph.D., ABIHM

Board Certified in Medical Oncology

Board Certified in Integrative and Holistic Medicine

6/30/2025

Q: Hi Dr. Zhang, I know you’re a board-certified medical oncologist. I’m curious, what got you interested in using off-label medicine?

A: That’s a good question. My journey into off-label medicine started back when I was an intern at Columbia. One of my senior residents was doing lab research on statins for colon cancer, and it really caught my attention. Then in 2001, after I graduated from Yale, I went to a free dinner talk about ACTOS, which is a diabetes drug. While I was listening, I realized it might actually work as a cancer treatment too, based on what I knew from cancer research. The drug blocks a key signaling pathway that cancer cells use. I decided to try prescribing ACTOS to a few of my patients who had no other good options, including one with stage 4 colon cancer and about a dozen with pancreatic cancer. Amazingly, they all lived much longer than what the textbooks said they would.

Q: That’s pretty interesting. What did you do next?

A: Back then, I really wanted to dive deeper into research. So I ended up moving to Baylor College of Medicine as an assistant professor. I was seeing patients a couple of days a week and spending the rest of my time in the lab with my postdoc. We got some funding from the Duncan Scholarship, which helped us pull together a team from Texas A&M, MD Anderson, and UT Houston. We put our heads together and came up with a plan to do high-throughput multi-drug screening. Basically, we used robots to handle tons of drugs and ran a crazy number of experiments, all trying to find super cocktails against cancer using off-label medicines. We really focused on targeting cancer stem cells.

A: Once we set everything up, we started seeing some early results. We also brought in this machine called SEAHORSE, which let us watch cancer metabolism happen in real time, especially things like mitochondrial respiration. Along the way, we found some really powerful combos, like Actos, Sunitinib, and Gemcitabine. But, like a lot of research stories, we eventually ran out of money and couldn’t get more to keep it going. Even so, I’ve kept that spirit alive and still explore off-label medicines in my clinic today.

Q: I’m really glad you’re keeping the momentum going with the off-label treatments. So what can I expect during my consultation at Omega Precision Oncology Clinic?

A: At Omega Precision Oncology Clinic, we take a big-picture approach to cancer care. If you’re wondering what happens during your consult, here’s what we usually go over.First, we talk about diet and nutrition. We’ll ask what you’re currently eating, listen to any concerns you have, and give you personalized suggestions that can support your health and treatment.Next is supplements. A lot of people take vitamins or herbs, and we’ll go over what you’re using. We’ll tell you what’s helpful, what might be risky, and what’s probably not necessary—based on science, not hype.We also use off-label medicines—these are repurposed drugs originally made for other conditions but may help in cancer care. We’ve put together a list of around 20 medicines we commonly work with, and we tailor them to your medical condition, based on the latest research, and how you’re responding to treatment.

A: We’ll also talk about other treatment ideas like IV vitamin therapy, plasma exchange, and fecal microbiota transplants. We don’t offer things like ozone therapy, EBOO, or hyperbaric oxygen therapy, but we’re happy to talk about them and give you an honest, science-based opinion.We also guide you through standard treatments like chemotherapy, immunotherapy, targeted therapy, and even low-dose chemotherapy. And if you’ve had genetic testing—like next-generation sequencing, or NGS—we can help you make sense of it. NGS looks at the DNA and mutations in your tumor to find possible targets for treatment. It’s one of the tools we use to help personalize your care.Our goal is to bring together solid research, clinical data, treatment guidelines, and real-world experience—all in one place, working with you through shared decision-making. We’re open to any treatment approach as long as there’s real data behind it. But we don’t recommend things just because they sound good in theory or showed early promise in a mouse study. We want what’s safe, evidence-based, and truly helpful for you.

Q: I’m really glad I’m meeting with you. You’re not just a well-trained and experienced oncologist, but also a research scientist. I actually have a lot of questions about off-label medicines. But before we dive into that, let me ask you this first: could you take a look at my diagnosis, my genomic profile, my cancer metabolism, the Warburg effect and all that, and come up with a treatment plan that’s unique and personalized for me?

A: Thank you, that’s a great question. It sounds like a really exciting idea, right? Crafting a totally unique and personalized treatment plan for each patient and getting amazing success rates. But honestly, the short answer is no. Let me explain why.For decades, we’ve been hunting for the key mutation, the so-called Achilles’ heel of cancer, hoping to design a drug that could wipe it out. And we did have some wins — like chronic myeloid leukemia, where one mutation, the BCR-ABL, can be targeted and pretty much cured with one drug. But for most other cancers, even if we find a gene to target, the best we usually get is a few extra months of life, not a cure. And pretty soon, within months or maybe a year or two, the cancer figures out a way around the drug.The problem is how we look at cancer — we have been way too focused on breaking it down into tiny pieces.

A: What we really need is a big-picture approach, looking at cancer as a system, like systems biology.Now, when you zoom in and look at details like which genes are mutated or which pathways are switched on — say, the fat metabolism pathway in colon cancer, or the glycolysis pathway — cancer looks different. Every patient seems a little unique. But if you zoom out and look at the whole system, you realize something important: deep down, all cancers are basically the same. Sorry, but nobody’s cancer is truly one-of-a-kind. They all share the same basic 10 hallmarks, whether it’s colon, breast, or any other type.So if we really want to get rid of cancer, we can’t just chase the so-called unique features. We have to hit all the common features, even the ones we can’t see at the moment. Just because you don’t see it doesn’t mean it’s not there — maybe it’s hiding out in your liver or lungs, just waiting.

A: That’s why trying to only focus on a few mutations or pathways is a bad idea. Instead, we need to attack all the pathways at once if we want a real chance to wipe cancer out for good. And while using 10 chemotherapy drugs at the same time would be way too toxic — unless you’re treating something like acute leukemia — we can actually do this with off-label medicines. A lot of them are pretty gentle compared to chemo.In short, cocktails of off-label medicines and supplements are a much better strategy than trying to create a super customized plan based on one patient’s specific mutations. It’s about using everything we know about cancer biology today to build a treatment that covers all the bases.

Q: How does the off-label combination therapy work?

A: This cocktail targets multiple cancer hallmarks at the same time. Rather than focusing on just one pathway, these drugs are designed to interfere with several key mechanisms that cancer cells depend on—such as energy metabolism, immune evasion, inflammation, and cell survival.The goal is to weaken the cancer cells by disrupting these critical functions and to modify the tumor microenvironment so it’s less supportive of cancer growth. By doing this, we increase the effectiveness of traditional therapies like chemotherapy, radiation, or immunotherapy It’s a systems-based strategy that works across cancer types by hitting shared vulnerabilities.

Q: I read Jane McLelland’s book, How to Starve Cancer, and she mentioned the MetroMap for cancer metabolism. Does the off-label medicine cocktail cover all those pathways?

A: Absolutely. The off-label medicine cocktail interferes with the metabolic networks that cancer cells rely on to grow and survive. This idea lies at the heart of cancer metabolism, which is a key focus within the broader field of systems biology and systems medicine—fields that aim to understand and disrupt the interconnected processes cancer cells use to thrive.As I mentioned earlier, our approach is centered around targeting the core hallmarks of cancer. Metabolic reprogramming, which Jane illustrates in her MetroMap and emphasizes throughout her book, is one of the ten hallmarks. Cancer cells often depend on aerobic glycolysis, also known as the Warburg effect, where they rapidly consume glucose even when oxygen is available. But that’s only part of the picture. Many also rely on alternative fuel sources like glutamine, fatty acids, and even lactic acids to support their energy needs and build new cells.

A: The off-label protocol we use is designed to block multiple points across these fuel pathways. It not only restricts the cancer cells’ primary energy sources but also makes it harder for them to switch to backup fuel routes like glutamine metabolism. Over time, this can weaken the cancer’s ability to grow, spread, or resist treatment.By limiting their access to fuel and disrupting their adaptive mechanisms, metabolically stressed cancer cells may become more sensitive to chemotherapy, radiation, and immunotherapy. And yes—our combination therapy is mapped to cover all major metabolic pathways featured in the MetroMap, using a layered, coherent approach supported by published research and clinical insight.Last but not least, I want to add that the cocktail we use doesn’t just interfere with cancer’s fuel metabolism—it also impacts cancer stem cells, inflammation, and several other cancer hallmarks that go beyond what’s shown in the MetroMap. This broader, systems-based strategy is what gives our approach both flexibility and strength.

Q: Who is the off-label medicine cocktail intended for? Does it apply to my type of cancer?

A: The off-label medicine cocktail we use targets the core hallmarks of cancer—biological traits that are shared across almost all cancer types, no matter where they start or what stage they are in. These include abnormal ways of producing energy, heavy dependence on certain nutrients, chronic inflammation, stress survival mechanisms, cancer stem cell activity, and the ability to evade the immune system. These features allow cancer cells to grow uncontrollably, avoid death, invade other tissues, and resist standard treatments.The concept of cancer hallmarks was introduced to explain the shared strategies that cancer cells use to survive and spread. While each cancer may look different on the surface, at a deeper level, they rely on similar biological processes. Our approach targets several of these processes at the same time—especially those related to metabolism, inflammation, immune evasion, and stemness.

A: Because these traits are common across many types of cancer, our protocol is considered cancer-agnostic. It may be appropriate for patients at any point in their cancer journey—whether newly diagnosed, in remission, or facing progression. Instead of focusing solely on tumor type or genetic mutation, we take a systems biology approach, addressing the underlying weaknesses that most cancers share. This makes our strategy broadly applicable to most cancers and often complementary to chemotherapy, immunotherapy, radiation, and other conventional treatments.

Q: Dr. Zhang, how many off-label medications are actually used in cancer treatment? And which ones are most commonly used at your clinic?

A: Great question. There are actually a lot—well over a hundred off-label medications have shown potential in cancer care, based on lab research, clinical studies, and case reports. Some of the better-known ones include metformin, mebendazole, ivermectin, doxycycline, statins, and celecoxib. Now, we don’t use all of them for every patient. We carefully narrow the list based on available clinical data, how the patient is doing, how the medicine fits with their standard cancer treatment, and whether there are any important drug interactions. And just to clarify—not all drug interactions are bad. In some cases, they can actually make treatment more effective when used the right way.At our clinic, we more commonly use medications like metformin, mebendazole, itraconazole, doxycycline, celecoxib, Pitavastatin, propranolol, hydroxychloroquine, dipyridamole, pioglitazone, ivermectin, and occasionally others like niclosamide, disulfiram, and dimethyl fumarate

A: We base our choices on a mix of real clinical experience, published research, and a solid understanding of the pharmacology behind each drug—how it works, how it interacts with other medications, and how it might influence treatments like chemotherapy or immunotherapy.And I should add—our approach is usually not based on the cancer type. Instead, we take a more cancer-agnostic approach. Like I’ve mentioned before, we see cancer as a systems biology issue. We’re focused on targeting the shared hallmarks of cancer—those common traits that almost all cancers rely on to grow, spread, and survive—no matter where they started.

Q: How do I know if the treatment I’m getting at Omega is actually helping me?

A: At Omega Precision Oncology, it’s not always easy to pinpoint which part of your treatment is making the biggest impact—whether it’s the integrative protocol we offer or the standard therapies you’re also receiving. The reality is, both are backed by strong research, and in practice, they often work together in a complementary way. Rather than trying to separate which element is doing what, our focus is on helping you get the best overall result. We base our approach on clinical studies and a thorough review of the medical literature, but we also recognize that every patient’s journey is unique. Most of the time, it’s the synergy between your conventional treatments and our integrative strategies that creates the strongest effect.

Q: How will you track my progress while I’m taking off-label medications and supplements?

A: We monitor your progress using a combination of imaging and lab tests. This includes scans like CT, MRI, or PET, along with tumor markers such as CA 15-3, CA 27.29, CEA, CA 19-9, and AFP. Most of the time, your primary oncologist will already be ordering these as part of your standard care, and sharing the results with us allows us to adjust your protocol if needed.We also use advanced molecular tools like Signatera and Guardant Reveal to track your tumor burden more precisely through circulating tumor DNA (ctDNA). These tests give us a real-time view of how your cancer is responding at the molecular level. In many cases, your oncologist may already be ordering them, but if not, we can help you get them set up.While these are high-end tests, Signatera and Guardant Reveal are often covered by insurance.

Q: Thanks, Dr. Zhang. Can you briefly explain the 10 hallmarks of cancer?

A: Sure, happy to explain. So, the 10 hallmarks of cancer are basically the common moves cancer cells make to grow, survive, and spread. No matter what kind of cancer we’re talking about—breast, colon, lung—they usually follow the same playbook.First, they just keep growing and dividing, even when your body tells them to stop. And unlike normal cells, they don’t die when they should—they sort of become immortal. They also figure out how to build their own blood supply, so they can keep feeding themselves. That’s how tumors get bigger.They don’t respect boundaries either. They push through tissues and can travel to other parts of the body, which is what we call metastasis. Plus, they’re sneaky—they know how to hide from the immune system, so your body doesn’t fight them off effectively.They also change how they make energy. Instead of using oxygen the normal way, they switch to burning sugar fast, which helps them grow even faster. And they stir up inflammation, which actually helps them out instead of hurting them. Finally, they mess with their own DNA to evolve quickly and hijack normal survival signals.Bottom line—different cancers may look different on the surface. They might have different mutations or unique features. But underneath, they all use the same set of tricks to some degree.

Q: So, how long am I supposed to stay on this off-label medicine combo?

A: At Omega Precision Oncology Clinic, the duration of your treatment protocol depends on your ongoing cancer care plan and other individualized factors. This is something we’ll continue to discuss during your appointments. For patients at average risk, our general approach is to maintain the protocol for about 2 to 3 years, followed by a gradual reduction in medication intensity. The medications and dosages are tailored over time based on your treatment response, standard-of-care therapies, and tolerance. Once you reach the three-year mark and are doing well, we will reassess long-term benefits and risks. Some medications we use are safe for lifetime use, while others are more appropriate for shorter-term courses, such as two years. We will revisit and adjust the plan as you reach key treatment milestones

Q: What blood tests should I get to keep an eye on side effects from my off label medications?

A: The blood test panel we use includes a Complete Blood Count (CBC) and a Comprehensive Metabolic Panel (CMP). The CMP checks your kidney function—things like BUN, creatinine, and calcium—as well as your liver function, including bilirubin, ALT, albumin, alkaline phosphatase, GGT, globulins, and total protein. We also check vitamin D levels and G6PD.We typically don’t include tests like HbA1c or cholesterol panels, even though some of the medications we use were originally developed for diabetes or high cholesterol. That’s because in our clinic, we’re using these medications as part of a cancer treatment strategy—not to treat diabetes or lipid issues directly.Regular testing of CBC, CMP, vitamin D, and G6PD helps us monitor for side effects that might affect your immune system, blood counts, kidney or liver function, and to make sure it’s safe for you to continue high-dose vitamins or supplements. These tests are important for your safety.In many cases, your oncologist may already be ordering these labs, so we just need a copy of the results. You can usually access them through your MyChart account or directly from your oncology clinic.

A: If you’re having trouble getting the tests done, we can help by placing an order for you through Quest Diagnostics. The process is done online, and both you and our team will have access to the results at the same time. Most of the time, these lab tests are covered by insurance.

Q: How often should I have blood tests done?

A: We usually recommend doing blood work—like a CBC and CMP—every 1 to 3 months to keep an eye on any potential side effects. This helps us monitor things like your liver and kidney function, blood counts, and overall safety. The exact timing may vary depending on your treatment plan and how you’re feeling, so we’ll tailor the schedule to your specific needs.

Q: Can I share the blood test results I get from my local oncologist with you?

A: Absolutely. Sharing your lab results with us helps us stay in sync with your overall care team and avoid repeating tests unnecessarily. It also allows us to make better-informed decisions about your treatment while keeping things simple and coordinated for you.

Q: What should I do if my blood cell counts go down while I’m taking off-label medications from Omega Precision Oncology?

A: If your blood counts fall, pause your medications temporarily and repeat your lab work in one to two weeks. Make sure to go over the results with both your primary oncology team and Omega Precision Oncology. Many standard treatments—not just off-label therapies—can influence blood cell levels, so coordinated review is key to making safe and informed decisions.

Q: What should I do if my liver function tests come back abnormal after starting treatments prescribed by Omega Precision Oncology Clinic?

A: If your liver tests are abnormal, the first step is to pause the treatments prescribed by Omega Precision Oncology Clinic and repeat the blood work in about two weeks. It’s also important to inform your primary oncologist. Liver changes can be caused not only by off-label medications and supplements, but also by chemotherapy, oral targeted therapies, or immunotherapies like Keytruda. Keeping your entire care team informed allows everyone to work together to evaluate the cause and adjust your treatment plan safely.

Q: What should I do if I have nausea or vomiting while on treatments from Omega Precision Oncology Clinic?

A: If you experience nausea or vomiting, it’s best to pause the treatments prescribed by Omega Precision Oncology Clinic and see if your symptoms improve. Be sure to also talk to your treating oncologist, since many standard cancer treatments—like chemotherapy, targeted therapy, or immunotherapy—can also affect your digestive system. Keeping both teams informed helps ensure your care stays safe and coordinated.

Q: What should I do if I feel dizzy while on treatments from Omega Precision Oncology Clinic?

A: Some of the medications prescribed by Omega Precision Oncology Clinic can occasionally cause dizziness. If you start feeling dizzy, pause the treatments and see if your symptoms improve. It’s also important to let your primary oncologist know, as dizziness can also be a side effect of many standard cancer treatments. Keeping both care teams informed helps us evaluate the cause and adjust your treatment safely.

Q: I’m experiencing significant diarrhea while taking off-label medications from Omega Precision Oncology. What should I do?

A: Temporarily hold your medications and observe whether your symptoms improve. Diarrhea can be caused by many cancer-related treatments, not just integrative or off-label therapies. Make sure to discuss your symptoms with both your primary oncology team and Omega Precision Oncology, so your care can be adjusted appropriately and safely. Just so you know, some of the medications we often use here at Omega Precision Oncology can cause diarrhea—sometimes pretty commonly. It’s something to keep an eye on.

A: Here are the ones we see that with most often:Metformin – Up to 53%Sulfasalazine – Up to 20%Mebendazole – 3–10%Dimethyl fumarate – 14–18%Diclofenac ER – 5–15%Hydroxychloroquine – Up to 10%Doxycycline – 5–10%If you start noticing loose stools or stomach upset, it might be one of these. Let us know so we can help you manage it early and keep things on track.

Q: What’s the best way to take these medications?

A: Some medications work best when taken with food, others on an empty stomach, and some can be taken either way. Understanding when and how to take your medications helps improve both their effectiveness and how well you tolerate them. For example, metformin and mebendazole should be taken with meals. This not only helps the body absorb the drug more efficiently but also reduces stomach upset. Doxycycline and atorvastatin, on the other hand, are more flexible. You can take them with or without food—whichever fits better into your routine. If you’re fasting, metformin is generally safe to continue. But it’s important to stay alert for signs of low blood sugar—things like dizziness, sweating, or feeling shaky. If that happens, pause and reassess. And always feel free to reach out to your care team for guidance. These little adjustments can make a big difference in keeping your treatment on track while protecting your well-being.

A: Medications That Should Be Taken With MealsThese drugs are best taken with food to improve absorption or reduce stomach upset.Metformin – reduces GI side effects like nausea and diarrheaMebendazole  or Albendazole – better absorbed with fatty mealsItraconazole (capsules) – requires food and an acidic drink for absorptionSulfasalazine – lowers GI irritation risk when taken with meals and waterNiclosamide – better absorption with fatty foodsDimethyl fumarate – taking with food reduces flushing and diarrheaCelecoxib – food lowers risk of GI discomfortDiclofenac ER – reduces GI toxicity and helps with long-term use

A: Medications That Should Be Taken On an Empty StomachSome medications are best taken on an empty stomach — typically at least one hour before or two hours after a meal — to improve absorption.Disulfiram falls into this category. It’s better absorbed without food, but if it causes any stomach discomfort, taking it with food is acceptable. The most important thing is to avoid alcohol completely while on this medication.Dipyridamole is also recommended on an empty stomach for optimal absorption. That said, if it causes nausea, it’s reasonable to take it with food.Ivermectin has traditionally been given on an empty stomach for treating parasitic infections. However, in our anticancer protocols, we intentionally pair it with fatty foods to boost absorption and efficacy.

A: Medications That Can Be Taken With or Without FoodThese drugs are flexible—just be consistent with how you take them.Doxycycline – take with food if stomach upset occurs; avoid dairyAtorvastatin Pitavastatin Zypitamag – can be taken with or without food; bedtime often preferredPropranolol – with or without food, but take it the same way every dayHydroxychloroquine – with food may reduce nausea, but not requiredPioglitazone – food optional; take at the same time dailyDoxycycline is available in two formulations: hyclate and monohydrate. While both are effective antibiotics, doxycycline monohydrate is often better tolerated in individuals with sensitive stomachs. It’s associated with a lower risk of gastrointestinal side effects, making it a preferred option for patients prone to nausea or digestive discomfort.

A: So here’s the deal — most of these meds can be taken with food, no problem. The main exceptions are dipyridamole and disulfiram, which are generally recommended on an empty stomach for better absorption. But honestly, if they upset your stomach, it’s totally okay to take them with food instead. Comfort matters. Now, a few of these actually work better when taken with a fatty meal, especially when we’re using them in cancer care to boost absorption. Ivermectin is one of them — fatty food significantly increases how much your body absorbs, and we use that to our advantage. Celecoxib is another; a high-fat meal helps it absorb better and also eases potential stomach irritation. Itraconazole (specifically the capsule form) is best taken with a fatty meal too. Just a heads-up, the liquid version actually works better on an empty stomach. Niclosamide isn’t as well-studied in this area, but there’s some evidence suggesting that fat may help its absorption, especially when we’re using it for things like cancer, not parasites. And mebendazole — definitely take it with fat if you want it to work throughout the body and not just in the gut..

Q: Is it better to start all my medications at once or introduce them one at a time?

A: To minimize the risk of side effects and help identify any potential adverse reactions, it’s generally best to start medications one at a time. This approach makes it easier to pinpoint which drug may be responsible if you experience an issue. By introducing them gradually, you give your body time to adjust—and your care team the clarity they need to guide you safely.

Q: In what order should I introduce these medications?

A: The specific order isn’t critical. What matters is introducing each medication one at a time, with a 3-day interval between additions. This spacing allows you to clearly monitor for any side effects and gives your body time to adjust. Keep a calendar or medication diary to track your start dates and note any symptoms you experience. If a side effect occurs after adding a new medication, make a note, then hold that medication and observe whether the symptom resolves. If it does, write down when it disappears. Later, try reintroducing that same medication. If the symptom returns, that confirms a likely connection between that drug and the side effect. Share this with your care team—we can modify the dose, adjust the schedule, or switch to a different formulation to help you tolerate it better.

Q: I understand there’s no required order for starting these medications, but could you give me an example I can follow?

A: Certainly. While the sequence isn’t set in stone, a smart approach is to begin with medications that have the lowest risk of nausea or vomiting and gradually work up to those that are more likely to cause gastrointestinal side effects. This gives your body time to adjust and helps identify any side effects more clearly. Here’s a sample order—space them out by 3 days each:Pitavastatin, propranolol, dipyridamole, pioglitazone, ivermectin, celecoxib, disulfiram, diclofenac ER, hydroxychloroquine, mebendazole, niclosamide, doxycycline, itraconazole, sulfasalazine, metformin, and dimethyl fumarate.Of course, you may not be prescribed all of these medications. If something isn’t part of your personal treatment plan—for example, not everyone uses disulfiram or dimethyl fumarate—just skip it. Focus on the ones that are relevant to you.Keeping a medication diary or marking your calendar with start dates and any side effects can really help both you and your care team monitor your progress and adjust as needed.

A: For your reference—and to help you set expectations—it may be helpful to see how these medications compare in terms of nausea and vomiting risk. Below is a general ranking from least to most likely to cause gastrointestinal upset. This overview can give you a clearer mental picture as you work through your treatment plan:Knowing this in advance can help you plan your med schedule and recognize side effects early. Always feel free to reach out if symptoms arise—we’re here to help fine-tune your treatment so it works with your body, not against it.

A: Pitavastatin (Zypitamag) – RarePropranolol – RareDipyridamole – Less than 2%Pioglitazone – Less than 2%Ivermectin – 1–5%Celecoxib – 3–5%Disulfiram – Around 5%, primarily if alcohol is consumedDiclofenac ER – Around 5%, especially on an empty stomachHydroxychloroquine – 5–10%Mebendazole – 5–10%Niclosamide – 5–10%Doxycycline – 8–10%, higher risk without foodItraconazole – 10–15%, dose-dependentSulfasalazine – Up to 20%, especially early onMetformin – 20–30%, often during initial weeksDimethyl fumarate – Up to 40%, commonly early in treatment

Q: Should I alternate the off-label medications—like taking mebendazole in the first month, doxycycline in the second, and then back to mebendazole in the third?

A: No, we do not recommend alternating these medications month by month or cycling them individually. The strength of this approach lies in the synergistic effect that results from using all the agents together. Each one targets a different aspect of cancer cell metabolism, and when combined, they create a more comprehensive disruption of the cancer cells’ survival mechanisms.This multi-targeted strategy may also enhance the effectiveness of standard treatments such as chemotherapy or radiation. If tolerance becomes an issue, we can adjust the dose or provide breaks as needed. However, the overall goal is to maintain all medications together and consistently, rather than using them in rotation.

Q: What if I experience side effects or have concerns about the medications and supplements?

A: If you notice any side effects or start to feel unwell, it’s important to stop the medication or supplement and reach out to us right away. Common side effects may include nausea, vomiting, abdominal cramping, fatigue, dizziness, fainting, muscle aches, diarrhea, changes in urine color, or skin discoloration.We can adjust your treatment plan to help reduce or manage these symptoms. Everyone responds differently, so open communication is key. Letting us know how you’re feeling allows us to make sure your treatment stays safe, effective, and tailored to your needs

Q: What are the common side effects of pitavastatin (Zypitamag or Livalo), and when should I take it?

A: Pitavastatin, also known by brand names like Zypitamag or Livalo, is a cholesterol-lowering medication in the statin family. Like all medications, it can cause some side effects. The most common ones include muscle pain or weakness (reported in about 2–9% of patients, depending on the dose), constipation (1–3%), diarrhea (less than 2%), and back pain (1–2%). Some people also report mild rash or extremity pain, but those are rare. Pitavastatin can occasionally raise levels of creatine kinase (CK) and liver enzymes (ALT or AST), usually in 1–3% of people, though serious changes are uncommon. In very rare cases, patients may experience increased blood sugar levels, memory fog, or confusion. An extremely rare side effect that has been reported in case studies is lichen planus, a skin condition.

A: As for when to take pitavastatin, the good news is you have some flexibility. Unlike older statins that must be taken at night, pitavastatin can be taken at any time of day, thanks to its long-lasting effect. Some people still choose bedtime dosing since the body makes most of its cholesterol overnight, but what matters most is picking a time you can stick to consistently. And don’t forget—routine bloodwork is recommended to monitor liver function and muscle health while you’re on this medication.A

A: PitavastatinBack pain – uncommon, estimated in 1–2% of patientsConstipation – reported in 1–3%Myalgia (muscle pain) – relatively common, occurs in 2–9% of patients, dose-dependentDiarrhea – uncommon, <2%Extremity pain – rare, <1%Rash – uncommon, <2%, usually mildCreatine kinase (CK) elevation – occurs in ~1–3%, more significant elevations are rareALT or AST elevation – ~1–3%, usually transient; persistent elevations >3x ULN occur in <1%Increased glucose – small increases in fasting glucose noted; incidence of new-onset diabetes estimated in ~0.2–0.5% over 1–2 yearsCognitive impairment (e.g., memory loss, confusion) – very rare;

Q: What are the side effects of propranolol ?

A: Propranolol is generally considered safe and well-tolerated, with a long track record in managing cardiovascular and neurologic conditions. However, like all medications, it can occasionally cause side effects.The most commonly reported side effects include fatigue, dizziness, and gastrointestinal symptoms such as nausea, diarrhea, or constipation. These usually appear early in treatment and often improve over time.Because propranolol lowers heart rate and blood pressure, some individuals may experience bradycardia or hypotension, which can cause lightheadedness or fainting. It may also lead to sleep disturbances like insomnia, or mood changes such as depression in a small percentage of users.In rare cases, propranolol may affect sexual function, leading to impotence, or cause allergic-type reactions like skin rashes or hair thinning.It’s important to remember that most people tolerate the medication well. Any concerns or unusual symptoms should be discussed with a healthcare provider so the treatment can be adjusted if needed.

A: PropranololFatigue – common, reported in 5–15%Dizziness – common, about 5–10%Constipation – less common, 1–4%Bradycardia (slow heart rate) – dose-dependent, up to 5–10%Hypotension (low blood pressure) – common, 3–9%,Depression – reported in 1–5%,Disorientation or confusion – rare, <1%Nausea – reported in 2–5%Diarrhea – less common, 1–3%Hypersensitivity reactions (e.g., rash, urticaria) – rare, <1%Purpura – very rare

Q: What are the common side effects of dipyridamole?

A: The most common one by far is headache. In fact, in one study, about 67% of people reported headaches on the first day of taking it—but the good news is that number dropped way down to just 3% after a few days. Your body gets used to it pretty quickly. Other possible side effects include feeling dizzy (around 3% to 8%), nausea (2% to 5%), and flushing or feeling warm (3% to 6%). Some people also notice low blood pressure or lightheadedness, diarrhea, stomach pain, or even vomiting—but those are less common, usually in the 1% to 3% range.A small number of people—about 1%—may get a rash, feel their heart race a bit, or experience ups and downs in their blood pressure. Most of these side effects are mild and tend to settle as your body adjusts.

A: Oral dipyridamole side effects Headache: 10% to 40%Dizziness: 3% to 8%Nausea: 2% to 5%Flushing: 3% to 6%Hypotension: 1% to 4%Diarrhea: ~1% to 3%Abdominal pain: ~1% to 3%Vomiting: ~1% to 2%Rash: ~1%Tachycardia: ~1%Blood pressure lability: ~1%A

Q: What are the common side effects of Actos (pioglitazone)?

A: Actos is generally well-tolerated, but like all medications, it can cause side effects—most of which are mild and manageable. Here’s a breakdown of the most commonly reported ones:Upper respiratory tract symptoms happen in about 8% to 13% of people. But don’t worry—these usually aren’t real infections. Most patients just notice a runny nose, mild congestion, or allergy-like symptoms, not true colds or flu.Headaches are fairly common too, seen in around 5% to 9% of patients. These are usually mild and don’t last long.Muscle aches or myalgia can affect about 2% to 5% of users. If you already deal with joint or muscle discomfort, it’s something to keep an eye on.Weight gain may occur, particularly at higher doses. About 2% to 10% of people report gaining weight. It’s often due to fluid retention, not just fat gain.Edema or swelling—especially in the legs or ankles—can happen in about 4% to 15% of people, and it’s more likely if you’re also on insulin.Gas or flatulence is reported by about 2% of patients. It’s not dangerous, just a bit uncomfortable. Most of these side effects improve over time or with dose adjustments. If you notice anything unusual or bothersome, it’s always best to check in with your doctor.

Q: Are there any serious side effects of Actos (pioglitazone)?

A: Yes, there are a few serious side effects to know about, though they’re pretty rare. Most people do fine on Actos, but it’s still good to be informed—especially if you’re taking it long-term or already have certain health issues.Let’s start with congestive heart failure (CHF). Actos can sometimes make heart failure worse, especially in people who already have heart problems. The risk goes up with higher doses or longer use. In folks with known heart conditions, about 1% to 5% might experience symptoms. Because of this, the FDA gave Actos a black box warning—the strongest warning they issue.Next, there’s the risk of liver problems. Serious liver injury is very rare—less than half a percent—but it’s been reported. That’s why your doctor may order some liver function tests when you first start taking it, just to be safe.Bladder cancer has also come up in some long-term studies. There’s a small bump in risk, especially if someone’s been on Actos for more than a year. The estimated risk is around 0.5%. That doesn’t mean the drug causes bladder cancer, but it’s something we keep in mind, especially if there are other risk factors.

A: Then there’s bone fractures, especially in women. In long-term use, women may have a higher chance of breaking bones—mostly in the hands, feet, or arms. The rate is around 5% to 7%.Now, even though that’s a lot of information, I want to reassure you—these side effects are uncommon. If you don’t have a history of heart issues or bladder problems, Actos is usually safe and works well. And with regular check-ins and blood work, we can keep an eye on everything while you’re on it.

Q: What are the side effects of ivermectin? Is it safe at high doses?

A: That’s a great question, and the answer’s a bit more nuanced than you might think. Most of what we’ve learned about ivermectin over the years comes from its use as a single-dose treatment for parasitic infections like river blindness (onchocerciasis). In those cases, people do often experience side effects—but here’s the thing: a lot of the symptoms, like itching, rash, or fever, aren’t actually from the drug itself. They come from the body reacting to the dying parasites. That reaction even has a name—Mazzotti reaction—and it’s basically an immune flare-up when large numbers of parasites are killed off quickly. But the more relevant data for people without parasite infections—like cancer patients or healthy individuals—comes from more recent studies, especially during the COVID-19 era and in healthy volunteer trials.In those studies, ivermectin was tested at much higher doses and for longer durations. We’re talking about:15 mg daily for 7 days60 mg three times per week for two weeksA single dose as high as 120 mg (which is around 2 mg/kg—that’s 8 to 10 times the standard antiparasitic dose)

A: And even at those high doses, ivermectin was generally well tolerated. No serious neurological problems were reported. The side effects people did report were pretty mild and looked a lot like placebo:HeadacheDizzinessNauseaMild abdominal discomfortOccasional loose stoolsMerck even ran a dose-escalation study to understand how the drug behaves in the body. They found that:Drug levels in the blood rose as the dose increased (as expected)The half-life was around 18 hoursThere was very little accumulation in the body, even when taken multiple timesTaking it with food boosted absorption significantly—over 2.5 times higher than on an empty stomachNow, what about using ivermectin in cancer care?As of 2025, there are no published clinical trials in humans testing ivermectin for cancer. Lab studies and animal models suggest it might have anti-cancer activity, but we just don’t have the human data yet to guide dosing or safety for that purpose.

A: Bottom line?In people without parasite infections—like cancer patients or healthy volunteers—ivermectin seems to be quite safe, even at doses much higher than what’s typically used for parasites. Most side effects are mild, and serious complications are rare. That said, because we don’t have cancer-specific data, it’s important to use caution and keep close monitoring if you’re considering it off-label.

Q: I heard that I need a high dose of ivermectin because I have a high-grade tumor. What’s your take on this?

A: The dose of ivermectin we use is based on available safety data from clinical trials and what we know about its pharmacology—not just on how aggressive a tumor is. From a medical standpoint, all malignant tumors are considered serious and life-threatening, and we treat each case with great care and attention.But that doesn’t mean using the highest possible dose of ivermectin is always the best approach. Higher doses can increase the risk of side effects without necessarily offering more benefit. We aim for a dose that balances safety and potential effectiveness, and we adjust as needed based on your individual situation.

Q: Dr. Zhang, I understand your point about high-dose ivermectin, but can you still write me a prescription for it if I really want to try it?

A: Yes, I can accommodate that—as long as you clearly understand the potential risks and acknowledge that this is being done at your request, not based on my standard recommendation.The typical dose we use is ivermectin 15 mg taken twice a day on Monday, Wednesday, and Friday, for three weeks on and one week off. If you choose a higher dose, there are two common approaches: either 60 mg three times per week for two weeks, or a single weekly dose as high as 120 mg. That 120 mg dose is roughly 2 mg per kg of body weight—about 8 to 10 times the usual antiparasitic dose.If you go with 60 mg, I recommend doing bloodwork (CBC and CMP) every two weeks. If you use 120 mg weekly, it’s best to monitor labs weekly. These labs help us track your liver, kidney function, and blood counts to ensure your safety throughout treatment.

Q: What are the side effects of Celebrex?

A: That’s a great question, and I’m glad you asked. Celebrex, also known by its generic name celecoxib, is a type of nonsteroidal anti-inflammatory drug (NSAID). It works by blocking an enzyme called COX-2, which is involved in inflammation and pain. Compared to older NSAIDs, it tends to be easier on the stomach, but like any medication, it can have side effects.Let me walk you through what we typically see.The most common side effects include:Headache, which affects about 15% of peopleIndigestion or heartburn, reported in about 10–13%Upper respiratory tract symptoms, like mild congestion or cold symptoms, in around 10–11%Diarrhea, which happens in 8–10%Abdominal pain and nausea, seen in about 5–8% of patientsSome people may experience occasional side effects like:Vomiting (3–5%)Skin rash (2–4%)Gas or bloating (2–3%)Mild swelling in the hands or feet (2–3%)Dizziness (2–3%)Less commonly, we monitor for:Mild, reversible increases in liver enzymes like ALT or AST (1–2%)Slight elevation in BUN, a kidney function marker, which is usually transient.

A: Overall, Celebrex is considered safe and effective for most patients, especially when used short-term or at the lowest effective dose. Compared to traditional NSAIDs like ibuprofen or naproxen, Celebrex has a lower risk of gastrointestinal ulcers or bleeding.Of course, if you have a history of heart, kidney, or liver problems, or are taking other medications, we’ll monitor a bit more closely. If you ever notice symptoms that are new or concerning, I encourage you to reach out so we can evaluate whether the medication is still appropriate for you.

Q: Thanks Dr. Zhang. Is there any serious side effect of Celebrex I need to be aware of?

A: Yes, there are some rare but serious side effects you should know about, even though they happen in less than 1% of people. These include:GI bleeding GI ulcer or perforation Heart attack (MI) Stroke Congestive heart failure (CHF) Kidney problems (nephrotoxicity)Liver injury (hepatotoxicity)These are uncommon, but the risk can go up if you take high doses, use it long-term, or have a history of heart, kidney, or liver issues. That’s why we usually keep an eye on your labs and adjust the dose if needed. For most people, Celebrex is safe and well tolerated when used at the right dose and for the right reasons.

A: Celebrex (celecoxib) side effectsHeadache – common ~15%Dyspepsia (indigestion) – common (~10–13%)Upper respiratory tract infection (URI) – common (~10–11%)Diarrhea – common (~8–10%)Abdominal pain – common (~5–8%)Nausea – common (~5–8%)Vomiting – occasional (~3–5%)Rash – occasional (~2–4%)Flatulence – occasional (~2–3%)Peripheral edema – occasional (~2–3%)Dizziness – occasional (~2–3%)ALT or AST elevated – uncommon (~1–2%), typically mild and reversibleBUN elevated – uncommon, may indicate kidney stress; often transientFever (in pediatric patients) – uncommon, context-specificCough (in pediatric patients) – uncommonArthralgia (in pediatric patients) – uncommonPhotosensitivity – rare (<1%)A

Q: What are the side effects of disulfiram? Are there any serious ones I should know about?

A: Yes, disulfiram can cause both common and rare but serious side effects. Most people tolerate it well, especially at standard doses, but you should be aware of the following:Serious Reactions (rare, <1% unless noted):Severe disulfiram-alcohol reaction – nearly guaranteed if alcohol is consumed; symptoms include flushing, chest pain, vomiting, hypotension, confusion; can be life-threatening in high doses of alcoholPsychosis – rare but reported, especially at high doses or in those with a psychiatric historyHepatotoxicity – liver enzyme elevations occur in up to 10%; serious liver injury is rare (<1%) but may require stopping the drugPeripheral neuropathy – rare; can present as numbness or tingling in hands or feetOptic neuritis – extremely rare; limited to isolated case reports

A: Common Reactions:Disulfiram-alcohol reaction (mild to moderate) – flushing, headache, sweating, nausea, palpitations; occurs in almost all patients who consume alcoholRash – occurs in ~10%Drowsiness – ~10–15%Impotence or reduced libido – ~5–10%Headache – ~10%Acne – ~5–10%Metallic or garlic-like taste – very common, ~10–20%Note: The disulfiram-alcohol reaction can occur even with small amounts of alcohol, including in cooking or mouthwash. Patients should avoid all alcohol-containing products.Most side effects go away after stopping the drug. Liver function should be monitored regularly, especially during the first few months.

Q: Dr. Zhang, what are the concerns or side effects of diclofenac?

A: Good question. Diclofenac is a nonsteroidal anti-inflammatory drug, or NSAID, and it works well for pain and inflammation—especially in arthritis or injury-related issues. But like all NSAIDs, it comes with some risks.The most common side effects are stomach-related—things like indigestion, nausea, abdominal pain, or diarrhea. You might also notice constipation, headache, dizziness, or even some swelling in the legs from fluid retention. Occasionally, people report a skin rash, itching, drowsiness, or ringing in the ears.We also watch for changes in liver enzymes, which can happen in a small percentage of patients. Kidney function can be affected too, especially in people who are older or dehydrated.

A: That’s why if you’re using it long-term, we usually check bloodwork every so often.Now, here’s something important: diclofenac carries the same black box warning as Celebrex and other NSAIDs. That means it may increase the risk of serious cardiovascular events like heart attack or stroke, especially with long-term use or in people with existing heart conditions. It can also cause serious gastrointestinal problems like ulcers, bleeding, or perforation.So while it’s an effective medication, we try to use the lowest effective dose for the shortest amount of time—and keep a close eye on things if you’re using it regularly.

Q: Dr. Zhang, what are the side effects of hydroxychloroquine? Should I be concerned?

A: That’s a very reasonable question. Hydroxychloroquine is generally well tolerated, especially when taken at standard doses and for shorter durations. However, as with any medication, there are some side effects to be aware of.The most common side effects are typically mild and manageable. These include nausea and abdominal discomfort, each occurring in about 5 to 10% of patients. Vomiting and diarrhea are also reported, though slightly less frequently, in about 3 to 6% of individuals. Some people—around 1 to 3%—may experience mild vision changes, such as blurry vision or trouble focusing, especially early in treatment. These symptoms are usually reversible once the medication is adjusted or discontinued.

A: There are also rare but more serious side effects, although these occur in less than 1% of patients:Retinal toxicity or retinopathy is one of the better-known risks, particularly with long-term use (typically after 5 years) or at high cumulative doses. The risk is around 1% at the 5-year mark and may increase up to 20% after 20 years of use. This is why regular eye exams are strongly recommended for anyone on chronic therapy.Hemolytic anemia may occur in individuals with G6PD deficiency, though this is rare.Agranulocytosis, a drop in white blood cells, is extremely uncommon but has been reported.QT interval prolongation, which affects heart rhythm, is also rare but may occur, especially in patients taking other medications that affect cardiac conduction.Fulminant hepatic failure is extremely rare, but liver function is monitored periodically during treatment as a precaution.In summary, hydroxychloroquine is considered safe for most people when used appropriately and monitored closely. We tailor the treatment to your specific health needs and ensure regular follow-up to reduce any potential risks.

Q: Dr. Zhang, what are the side effects of mebendazole? Is it safe to take?

A: For most people taking mebendazole, it’s generally very safe and well tolerated. The most common side effects are pretty mild. You might feel some abdominal discomfort or cramping, maybe a bit of diarrhea. A few people get a mild skin rash. These symptoms usually go away on their own and don’t need any treatment. If someone is on longer or high-dose  there are a few rare but serious side effects to be aware of. These include things like:Liver inflammation or hepatitis, Changes in liver enzymes on blood work (usually reversible)Low white blood cell counts, like neutropenia or even agranulocytosis, which are very rareIn extremely rare cases, things like seizures or allergic reactions like angioedema have been reported

Q: Dr. Zhang, what are the side effects of niclosamide? Is it generally safe?

A: Yes, niclosamide is considered one of the better-tolerated antiparasitic drugs. It’s been around for decades and is mainly used to treat tapeworm infections. Most of the side effects are mild and tend to resolve on their own. The most commonly reported include:Abdominal discomfort or cramping in about 3 to 5% of patientsNausea and vomiting, seen in roughly 2 to 4%Diarrhea, which occurs in around 2 to 3%An unpleasant or metallic taste, reported by about 1 to 2%Occasionally, people experience headache or dizziness, but these are less common, usually under 2%Overall, serious side effects are very rare. Most people tolerate it quite well.

Q: Dr. Zhang, what are the side effects of doxycycline?

A: Doxycycline is generally well tolerated, especially when taken correctly, but like any medication, it can cause side effects.The most common ones are gastrointestinal. Nausea happens in about 5 to 10% of people, and vomiting in around 2 to 5%. You might also get mild diarrhea, usually in about 1 to 5% of cases—it’s actually less common than with other antibiotics because doxycycline is so well absorbed in the gut. If the pill is taken without enough water or right before lying down, it can cause esophagitis or esophageal ulcers, though that’s uncommon—usually under 1%.We also see occasional skin reactions, like a rash in 1 to 3% of people, and photosensitivity—meaning your skin becomes more sensitive to sunlight—in about 1 to 4%.

A: In rare cases, doxycycline can affect the liver, leading to mild liver enzyme elevations or even hepatotoxicity, but this is seen in less than 1% of patients. It can also cause a mild, dose-related increase in BUN (a kidney marker), but that’s not something most people feel—it usually shows up only on lab work.As long as you take it with a full glass of water and avoid lying down right away, most of these side effects are avoidable or manageable.

Q: What are the side effects of itraconazole? Is it generally well tolerated?

A: Yes, itraconazole is generally well tolerated by most patients. However, it’s a medication that requires a bit more attention because it can interact with many other drugs—so we always check for drug-drug interactions before starting it.In terms of side effects, here’s what we see based on clinical data and post-marketing experience:Common side effects (happen in about 1% to 10% of patients) include:Nausea (about 3–9%)Vomiting (2–6%)Diarrhea (3–7%)Abdominal discomfort or indigestion (1–5%)Headache and dizziness (1–4%)Skin rash (1–4%)Peripheral edema, often dose-related (2–5%)Elevated liver enzymes (2–5%)Less common, but more serious side effects (occur in fewer than 1% of cases) include:Liver toxicity, including rare cases of liver failureCongestive heart failure—this is important enough to carry a black box warning, especially with long-term use or in patients with existing heart issuesPancreatitisWe monitor liver function during treatment and stay alert for any symptoms that might point to heart or liver issues.

Q: What are the possible side effects of sulfasalazine? Is it generally safe to use long-term?

A: Sulfasalazine is widely used for inflammatory conditions, and for many patients, it’s quite effective and tolerable. That said, like any medication, it comes with potential side effects—some are common and mild, while others are rare but more serious.Common side effectsHeadache10 to 20% of peopleNausea and vomiting, in about 5 to 15%Indigestion and abdominal pain, around 3 to 8%liver enzyme elevations (AST/ALT)Mild leukopenia (low white blood cell count)Hemolytic anemia (breaking down of red blood cells)Reversible low sperm count (oligospermia) in men—this usually improves after stopping the drugSensitivity to sunlight (photosensitivity)Rarely, you may see blood in the urine (hematuria) or crystal deposits in the urine

A: Less common but serious side effects (occur in less than 1% of people) include:Liver toxicity, including hepatitis or cholestatic jaundiceKidney toxicity, like interstitial nephritis or kidney failureLung inflammation, such as eosinophilic pneumonia or pleuritisPancreatitisWe monitor labs regularly, especially liver and kidney function, and blood counts.

Q: Metformin is one of the most commonly used medications. Do you have any concerns about using it in cancer patients?

A: You’re absolutely right—millions of people in the U.S. take metformin, and its long history of use tells us a lot about its overall safety. That said, when we use it in cancer care—especially off-label—we like to pay closer attention to its tolerability and side effect profile.The most common issue we see is diarrhea, which can affect up to 20% of patients, particularly when using the immediate-release form. In some people, it can be bothersome enough to require dose reduction or switching formulations.Here’s a quick rundown of common side effects (≥1% of users):Diarrhea: ~10–20%Nausea: ~5–10%Vomiting: ~2–5%Gas or bloating: ~1–5%Abdominal cramping: ~2–5%Indigestion: ~1–4%Appetite loss: ~1–3%Fatigue or weakness: ~1–3%Metallic taste: ~1–2%Headache: ~1–2%Skin rash: ~1%Vitamin B12 deficiency: ~6–9% with long-term useOvulation induction: observed in women with PCOS (not a side effect, but a pharmacologic effect)

A: Serious but rare side effects (<1%):Lactic acidosis: very rare but serious; mostly seen in people with kidney problems or acute illnessMegaloblastic anemia: due to B12 deficiencyLiver toxicity: very rare; isolated reportsFor patients who develop intolerable gastrointestinal side effects, especially diarrhea, we often use a transdermal (TD) formulation of metformin. Since it bypasses the gut, it can eliminate GI side effects altogether while still delivering the drug’s benefits—especially in cancer patients where gut sensitivity is more common.A A

Q: What are the side effects of dimethyl fumarate (DMF)?

A: The most common side effects we see with DMF are gastrointestinal—things like diarrhea, abdominal pain, nausea, and vomiting. Another frequent issue is flushing, which can affect up to 30–40% of patients, especially during the first month. While most cases are mild, a small number of patients may experience more intense flushing that can lead to stopping the medication.Flushing: ~30–40%Abdominal pain: ~10–18%Diarrhea: ~10–14%Nausea: ~10–12%Vomiting: ~6–8%Itching (pruritus): ~2–5%Rash: ~2–4%Indigestion (dyspepsia): ~2–4%AST elevation (liver enzyme): ~1–2%Mild to moderate lymphopenia: ~2–6% (usually temporary)

A: Serious but less common side effects (<1%)PML (Progressive multifocal leukoencephalopathy): very rare but serious; mainly in patients with severe or prolonged lymphopeniaProlonged lymphopenia: can last more than 6 months; interestingly, in certain cancers like lymphocytic leukemia, this is sometimes used as part of a therapeutic strategyLiver injury: rare, includes elevated liver enzymes or hepatitisAcute pancreatitis: very rare

Q: Dr. Zhang, it seems that liver toxicity is a big concern. Which medicines are the most worrisome?

A: Abnormal LFT:High Risk (≥5% or notable concern in clinical use)Itraconazole – up to 10% AST/ALT elevation; rare cases of serious hepatic failureDisulfiram – ~3–10% LFT elevation; rare hepatitis or liver failurePioglitazone – ~2–5% LFT elevation; rare liver failure (boxed warning in earlier years)Diclofenac (especially ER) – 5–15% mild LFT elevation; rare but serious hepatic injury reportedDimethyl fumarate – ~5–10% transient LFT elevations; rare severe hepatic injuryModerate Risk (1–4%)Celecoxib – ~1–3% AST/ALT elevations; lower risk vs. diclofenacPitavastatin (Zypitamag) – ~1–2% LFT elevation; class effect for statinsHydroxychloroquine – ~1–2%; rare hepatic injury, usually reversibleSulfasalazine – 1–3% LFT elevations; hepatitis and cholestasis reported

A: Low Risk (<1%)Doxycycline – rare, <1%, usually mild and reversibleMetformin – rare; transient elevations <1%, not typically hepatotoxic unless underlying liver diseaseIvermectin – rare, <1%; mild elevations in trials, including in COVID studiesMebendazole – rare, <1%; some reports in high doses or prolonged useNiclosamide – minimal systemic absorption orally; hepatotoxicity rarePropranolol – very rare; mild transaminase elevations reportedDipyridamole – very rare; not commonly associated with liver enzyme changes

A: You’re right—it’s one of the key things we watch for, especially when patients are on multiple medications. If your liver function tests (LFTs) come back abnormal, we’ll look closely at which drug might be the cause. Usually, we try stopping the one most likely to affect the liver. The good news is, it’s often reversible, especially if we catch it early. That’s why I always recommend doing labs every 1 to 3 months.Now, for the meds we keep the closest eye on:Itraconazole can raise liver enzymes in up to 10% of patients. In rare cases, it’s been linked to serious liver damage.Disulfiram also has a 3–10% chance of causing LFT elevation.Pioglitazone and Diclofenac both land around 5% or higher, and Dimethyl fumarate has a similar pattern.There are others with moderate risk—Celecoxib, statins like Pitavastatin, Hydroxychloroquine, and Sulfasalazine—usually in the 1–3% range.And then we have a group that rarely causes liver problems: Doxycycline, Metformin, Ivermectin, Mebendazole, Niclosamide, Propranolol, and Dipyridamole. These are generally very well tolerated when it comes to the liver.So if we ever see a bump in your LFTs, we’ll go through this list and make the safest adjustment.

Q: Dr. Zhang, I heard milk thistle can protect the liver. Can I take it for liver protection?

A: I get that question a lot, and honestly, I don’t recommend it in your case. Here’s why: your liver function tests—your LFTs—are one of the best tools we have to monitor how your liver is doing. The problem with milk thistle is that it might make those numbers look better on paper without actually fixing what’s going on inside the liver.It doesn’t stop fibrosis or reverse liver injury. So in a way, it can mask a problem by lowering the lab values while the real issue continues. That’s risky because it might delay us from stopping a drug that’s actually causing harm. So instead of adding milk thistle, it’s much safer to keep checking your labs regularly and remove the medicine that’s hurting the liver if we see any signs.

Q: What should I do if I experience side effects after starting a new medication?

A: If you develop side effects after introducing a new medication, pause that specific drug and continue with the rest of your regimen. Once you’ve completed the full sequence of remaining medications, you can consider reintroducing the one that triggered the reaction. If the symptoms return, this helps confirm whether that particular medication is the cause. Share your observations with your care team so adjustments can be made to better suit your needs

Q: What if the side effects persist when I reintroduce the medication?

A: If the same side effects return upon reintroduction, it’s a strong signal that the medication may not be well tolerated in its current form. In some cases, switching to an alternative formulation—such as from doxycycline hyclate to monohydrate—can reduce the adverse effects. It’s important to discuss this with us,  so the medication plan can be adjusted to maintain effectiveness while improving comfort and safety.

Q: Is it common to experience side effects with these medications?

A: While we recommend a gradual introduction of each medication to carefully monitor for side effects, the reality is that most patients tolerate these medications well. Taking them slowly—one at a time, with space in between—gives your body time to adjust and reduces the risk of discomfort. In my experience, most individuals are able to complete the full protocol without significant or disruptive side effects. Occasionally, we do encounter the need to stop a medication—for instance, metformin may cause gastrointestinal upset in some people. But we have workarounds: metformin can be compounded into a transdermal cream, which bypasses the stomach entirely and helps eliminate nausea or diarrhea.The key is communication. We’re here to support you every step of the way—to manage side effects, make adjustments, and keep your treatment safe, tolerable, and effective.

Q: My doctor told me my cholesterol is too low, so I cannot take statins. What is your opinion?

A: It’s understandable to be concerned about cholesterol levels becoming too low with statin use. However, numerous clinical trials indicate that it is safe to use statins even in patients with extremely low low-density lipoprotein (LDL) levels, including those with levels below 40 mg/dL, and it has been associated with improved survival. Therefore, I believe it is safe to take statins regardless of your already low cholesterol level. And remember, we use statins to treat cancer here, not solely for managing cholesterol levels.

Q: I was told statins are bad for memory and the brain. Can they cause dementia?

A: That’s a really common concern, and I understand why. Back in 2012, the FDA did issue a warning that statins might cause short-term memory issues in some people. But they also said very clearly that the heart benefits of statins far outweigh those risks.Now, more recent research has looked into this carefully—and there’s no solid evidence linking statins to dementia. Some people have worried that lowering cholesterol too much might affect the brain, or that statins might cross into the brain and cause problems. But those are more theories than proven facts.One large study followed nearly 19,000 people over about 4.5 years and found no connection at all between statins and memory loss or dementia. So, based on everything we know right now, statins are considered safe for the brain, and they don’t increase your risk of developing dementia.

Q: Doxycycline is an antibiotic, and I’m worried about how it might affect my gut health. What do we know so far?

A: That’s a great question, and one that comes up often. You’re right to think about your gut health—it’s important. So here’s what we know: doxycycline, like other antibiotics, can reduce the diversity of your gut microbiome while you’re taking it. But the story’s a little more nuanced than that. Interestingly, some studies show that doxycycline might lower the risk of C. diff infections—which are usually a sign of severe gut imbalance. It’s also used in cases of small intestinal bacterial overgrowth (SIBO), so it’s not all bad news. The even better news? For most people, the gut tends to bounce back pretty well. Research suggests the microbiome usually recovers within 1 to 4 weeks after stopping doxycycline. In cancer care, we often use a “2 months on, 1 month off” cycle to give the gut time to reset. In some cases, like with patients on cetuximab, we even use doxycycline continuously to manage skin side effects. So, all things considered, when we use it thoughtfully—especially with breaks built in—doxycycline is generally safe for the gut.

Q: Do I need to take probiotics if I’m on doxycycline?

A: While it’s not strictly required, taking probiotics alongside doxycycline can be a thoughtful way to support your gut microbiome. Antibiotics can disrupt the balance of bacteria in your digestive tract, and probiotics may help restore that balance more quickly.We’re supportive of using probiotics when appropriate. In fact, I often recommend them, especially during or after extended antibiotic use. Fermented foods such as kimchi, homemade yogurt, and kefir offer natural ways to maintain microbial health.If you prefer a supplement, look for one with multiple bacterial strains, which helps promote a diverse and resilient gut ecosystem. Trusted options include Bio-Kult and VSL#3.Additionally, for patients who are especially proactive, periodic microbiome testing—such as with TinyHealth fecal tests—can provide personalized insights and guide your gut health strategy over time.

Q: My blood sugar is in the normal range. Is it safe to take Metformin or Actos? And can both be taken together?

A: Yes, it is safe to use either Metformin or Actos—and even both together—even if your blood glucose levels are normal. These medications don’t typically cause hypoglycemia when used alone, especially in patients who aren’t on insulin or other glucose-lowering drugs.In oncology and metabolic health, we often use these medications for their broader benefits, such as reducing inflammation, improving insulin sensitivity, or targeting cancer metabolism. As always, we monitor your blood sugar regularly and adjust treatment as needed.If there are any signs that your glucose may be dropping too low—or if you have any symptoms—we can use a continuous glucose monitor (CGM) to get a clearer picture and manage things more precisely.

Q: My kidney function is low, and my family doctor said I can’t take metformin. What should I do?

A: That’s a very valid concern. The safety of metformin in people with impaired kidney function depends on the degree of that impairment. We base our decisions on a measurement called the glomerular filtration rate (GFR).Metformin is generally safe and appropriate for patients with a GFR above 30 mL/min/1.73 m². When GFR falls below 30, the risk of complications, such as lactic acidosis, becomes significant, and in that case, metformin is not recommended.We’ll review your latest kidney function tests and assess the risk together. If metformin isn’t appropriate, we can explore safe alternatives with similar benefits.

Q: Can I take fenbendazole?

A: Fenbendazole is not approved by the FDA for human use. That said, I know many people with cancer are choosing to take it. From what I’ve personally seen in patients who’ve used fenbendazole, it seems to be well tolerated. But I want to be clear—I can’t officially recommend or prescribe it because we don’t have strong human clinical data to prove it’s safe or effective in cancer. If you’re thinking about trying it, the decision is ultimately up to you. Like with any medication, if you do take it, monitor yourself closely for side effects and let your doctor know. One thing I advise: avoid using Panacur (the veterinary version), because it’s packed with fillers—up to 80% of the dose is not the active ingredient—and this can make dosing tricky or even lead to taking too much. If you decide to go ahead, I suggest looking into sources that offer pure fenbendazole powder. Some patients have mentioned options like Happy Healing or FenbenLabs. I’m not endorsing any company here—just giving examples. To be honest, outside of a few case reports, there isn’t solid clinical evidence yet. So while it might seem promising, it’s still an experimental approach. Please keep that in mind as you make your decision.

A: Do I have to stop fenbendazole to take mebendazole, or can I take both? I’ve heard fenbendazole is better than mebendazole.

A: You don’t necessarily have to stop fenbendazole to take mebendazole—some people choose to use them together. That said, combining the two could be reasonably safe, but it does need careful monitoring. We’d want to watch for any side effects or unexpected interactions.Mebendazole is FDA-approved for humans and something we can prescribe. Fenbendazole, on the other hand, is not officially approved for human use, so we rely more on case reports and patient experience rather than strong clinical studies.As for which one is better—there’s no head-to-head study comparing them, so we really can’t say one is clearly superior. Each has its own potential benefits, but until we have more solid data, it’s hard to make a firm recommendation either way.

A: We’ve spent a lot of time talking about side effects and safety concerns, and I get it — but I’m not taking these meds just to deal with side effects. Is there any actual data to support using them? I know they’re not part of standard care.

A: Yes, these medications do have risks, but in most cases, the risks are relatively low and can be managed with proper monitoring. More importantly, based on current research and clinical experience, the potential benefits may outweigh the risks, especially when used as part of a carefully considered plan. I’d be glad to share some of the most relevant and up-to-date studies involving real cancer patients — so you can see the evidence behind the approach.

A: ALBENDAZOLE: EVIDENCE

A: Cancer Chemother Pharmacol 2010/Phase I clinical trial to determine maximum tolerated dose of oral albendazole in patients with advanced cancer/Pourgholami/University of New South Wales, Australia.

A: Thirty-six patients with refractory solid tumors were enrolledMyelosuppression was the main dose limiting toxicity. Fatigue and mild gastrointestinal upset 4 /24 assessable patients (16%) had a tumor marker responseA decline in plasma vascular endothelial growth factor levels Albendazole was well tolerated on the schedule tested recommended dose for further study is 1,200 mg twice daily for 14 days in a 21-day cycleIn treating parasites, CDC recommends 400 mg BID for up to 6 months, or more than 6 months in HIV patients

A: Mebendazole in  Colon CancerThe Initial Case one

A: Nygren P, Larsson R. Drug repositioning from bench to bedside: tumour remission by the antihelmintic drug mebendazole in refractory metastatic colon cancer. Acta Oncol. 2014 Mar;53(3):427-8. doi: 10.3109/0284186X.2013.844359. Epub 2013 Oct 28. PMID: 24160353.

A: Mebendazole in  GI Cancer 10  Cases

A: 10 patients with advanced GI cancersMebendazole 4 g/day up to 8 weeksdemonstrate no clear treatment benefit, all patients experienced rapid disease progressionMebendazole was generally well-tolerated, even at the higher dose of 4 g per day.  need to be combined with a chemotherapy drug that halts tumor growthMebendazole is not recommended as a standalone treatment for cancer.

A: Niclosamide: Phase IB Trial in Prostate Cancer

A: Niclosamide doses reach 500mg TID, no detectable activityNiclosamide/PDMX1001 reach the dose of 1200mg TIDOf 8 pts, two pts achieved complete PSA response ( < 0.01 ng/ml), compared to historical control 0/30 pts treated with abiraterone  alone

A: Phase Ib trial of reformulated niclosamide with abiraterone/prednisone in men with castration-resistant prostate cancer; Sci Rep.2021 Mar 18;11(1):6377

A: Niclosamide: Phase IB Trial in Prostate Cancer

A: Phase Ib trial of reformulated niclosamide with abiraterone/prednisone in men with castration-resistant prostate cancer; Sci Rep.2021 Mar 18;11(1):6377

A: Continuous high-dose ivermectin appears to be safe in patients with acute myelogenous leukemia

A: Can show efficacy combined with chemotherapyThree children with refractory and heavily pretreated acute myeloblastyic leukemiaIvermectin was at 1 mg/Kg either alone or in combination with Ara-CTwo of them had clinical improvement with durable stable disease One  had  complete hematological responseIvermectin can be safely administered at dose five times higher the recommended  dose of 0.200 mg/Kg

A: de Castro CG Jr, Gregianin LJ, Burger JA. Continuous high-dose ivermectin appears to be safe in patients with acute myelogenous leukemia Leuk Lymphoma. 2020 Oct.

A: Long-term outcomes of first-line treatment with doxycycline in patients with previously untreated ocular adnexal marginal zone B cell lymphomaPublished: Annals of Hematology; 24 October 2014

A: Doxycycline 100 mg twice daily for 3 weeks (2 cycles)Number of Patients: 905-Year Progression-Free Survival: 60.9%Overall Survival: 100% at last follow-up

A: Repurposing itraconazole as a treatment for advanced prostate cancer: a noncomparative randomized phase II trial in men with metastatic castration-resistant prostate cancer

A: Antonarakis ES, Repurposing itraconazole as a treatment for advanced prostate cancer: a noncomparative randomized phase II trial in men with metastatic castration-resistant prostate cancer. Oncologist. 2013;18(2):163-73.

A: Itraconazole 600 mg/day

A: Suppressed Hedgehog signaling PSA stable or improved at 6 months: about 50%PSA reduction 50% in 15%Reduce circulating tumor cell No testosterone suppression

A: Arrieta O Effect of Metformin Plus Tyrosine Kinase Inhibitors. JAMA Oncol. 2019 Nov 1;5(11)

A: Effect of Metformin Plus Tyrosine Kinase Inhibitors Compared With Tyrosine Kinase Inhibitors Alone in Patients With Epidermal Growth Factor Receptor–Mutated Lung Adenocarcinoma

A: Metformin/Paclitaxel/ Carboplatin Nonsquamous Non-SmallCellLungCancer

A: Marrone KA, Zhou X, Forde PM, Purtell M, Brahmer JR, Hann CL, Kelly RJ, Coleman B, Gabrielson E, Rosner GL, Ettinger DS. A Randomized Phase II Study of Metformin plus Paclitaxel/Carboplatin/Bevacizumab in Patients with Chemotherapy-Naïve Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer. Oncologist. 2018

A: carboplatin,paclitaxel,and bevacizumab with metformin 1000 mg bid bevacizumab and metformin

A: Pioglitazone together with imatinib in chronic myeloid leukemia: A proof of concept study

A: Rousselot P, Prost S, Guilhot J, Roy L, Etienne G, Legros L, Charbonnier A, Coiteux V, Cony-Makhoul P, Huguet F, Cayssials E, Cayuela JM, Relouzat F, Delord M, Bruzzoni-Giovanelli H, Morisset L, Mahon FX, Guilhot F, Leboulch P; French CML Group. Pioglitazone together with imatinib in chronic myeloid leukemia: A proof of concept study. Cancer. 2017 May 15;123(10):1791

A: Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer

A: CALGB/SWOG 80702 (Alliance) Randomized Clinical Trial/JAMA. 2021 Apr 6; 325(13): 1277–1285

A: celecoxib 400 mg orally dailyy daily

A: 76.3%73.4%

A: 84.3%81.6%  P=.13

A: Phase II trial of infusional fluorouracil, leucovorin, mitomycin, and dipyridamole in locally advanced unresectable pancreatic adenocarcinoma: SWOG S9700

A: FU 200 mg/m2/d continuous intravenous (IV) LV 30 mg/m2 by IV weekly mitomycin 10 mg/m2 IV every 6 weeks up to four doses and dipyridamole 75 mg tid 1-year survival probability of 54%; The median survival was 13.8 monthsIn general, the treatment regimen was well tolerated.

A: Isacoff WH, Bendetti JK, Barstis JJ, Jazieh AR, Macdonald JS, Philip PA. Phase II trial of infusional fluorouracil, leucovorin, mitomycin, and dipyridamole in locally advanced unresectable pancreatic adenocarcinoma: SWOG S9700. J Clin Oncol. 2007 May

A: Hydroxychloroquine and Gemcitabine-Nab-Paclitaxel in Pancreatic Cancer Patients: Phase II

A: Hydroxychloroquine/gemcitabine/nab-paclitaxel chemotherapy; 600 mg twice dailygreater pathologic tumor responseimproved serum biomarker responseevidence of autophagy inhibitionEnhanced immune activity

A: 172

A: Zeh HJ, Bahary N, Boone BA, Singhi AD, Miller-Ocuin JL, Normolle DP, Zureikat AH, Hogg ME, Bartlett DL, Lee KK, Tsung A, Marsh JW, Murthy P  A Randomized Phase II Preoperative Study of Autophagy Inhibition with High-Dose Hydroxychloroquine and Gemcitabine/Nab-Paclitaxel in Pancreatic Cancer Patients. Clin Cancer Res. 2020 Jul

A: fumarate treatment in relapsed and refractory cutaneous T-cell lymphoma: a multicenter phase 2 study.

Q: Those are very exciting new patient results from real cancer cases. But I didn’t see any clinical trials for my specific type of cancer. Can I still take the medicine, even if there’s no trial data for my cancer?

A: Yes, it’s definitely possible. The truth is, it’s very difficult to study every single medicine in every single type of cancer—it takes time, funding, and large patient populations. But in integrative oncology, we often look deeper—at the biology and behavior of cancer itself, not just where it started in the body.Cancers across different types often share common features, or what we call the hallmarks of cancer. That’s why it’s reasonable to believe that findings from a trial in one cancer may still apply to others, especially when we understand how a drug works at the molecular level. That said, we always acknowledge the limits—we may not have definitive data for your exact cancer.Also, we’re not using these medicines one at a time—we’re combining them into a treatment cocktail. This strategy may target several cancer pathways at once, which could increase the chance of benefit.Ultimately, the decision to use these off-label medicines is made together, through shared decision-making. They’re not part of standard care, and you’re never obligated to take them. But based on what I’ve seen, I truly believe they offer meaningful benefits to many patients—and potentially to you as well. We’ll monitor carefully and adjust the plan as needed.

Q: Dr. Zhang, you prescribed me some off-label meds, but when I talked to my oncologist, they warned me that these drugs—like metformin, Zypitamag, and itraconazole—can cause nausea, vomiting, diarrhea, and liver damage. They said these could make chemo worse and advised me not to take them. What’s your take on this?

A: First of all, I really appreciate that your oncologist took the time to look into these medications. It shows they’re genuinely concerned about your safety and well-being, which is a good thing.That said, while the potential side effects are real and well-recognized, I believe their risks—when these medications are used thoughtfully and under proper medical supervision—are manageable and do not necessarily outweigh their benefits in cancer care. These off-label therapies are not given casually. We prescribe them with intention and precision, monitoring closely for any adverse effects. While some side effects may overlap with those of chemotherapy, in practice, most patients tolerate them well. In rare cases where side effects become an issue, we adjust the dose or pause the medication.My approach is not to dismiss these concerns, but to use clinical judgment, patient-specific context, and regular monitoring to guide safe and effective treatment. Ultimately, we are aiming to support your therapy—not hinder it—and I remain open to collaborating with your oncology team to make sure we all work together in your best interest.

Q: My doctor told me to stop the off-label medicines because there’s no strong evidence they help, and they’re not part of the standard of care. What should I do?

A: This is an important and thoughtful concern. It’s true—off-label medications are not part of standard oncology guidelines, and we fully acknowledge that. These treatments are not intended to replace standard care, but rather to complement it based on emerging scientific understanding and clinical experience.To our knowledge, the medications we use have a strong safety profile and generally do not interfere with conventional therapies. That said, if your treating oncologist has specific concerns, we welcome an open and respectful conversation. Our goal is to align with your care team and ensure your treatment remains safe and effective.If credible data shows that any of the medications we use could be harmful in your situation, we are always prepared to listen and make appropriate changes. Ultimately, your safety and well-being come first.

Q: My doctor reviewed my off-label medicines and told me to stop all of them because he believes they’re too dangerous. He said if I don’t stop, I need to find another oncologist. I like my doctor and don’t want to leave him—what should I do?

A: That’s a real dilemma, and I understand how hard this must be for you. If your doctor has a specific concern about one of the off-label medications—something he believes could seriously harm your health—we’re open to hearing that and reviewing it together. We’re flexible and willing to adjust your treatment if there’s a clear medical reason.But if your doctor completely rejects the use of off-label medications without any discussion, that may reflect a deeper difference in philosophy. Our approach is based on shared decision making (SDM)—which means you, as the patient, should be part of the conversation when weighing risks and benefits, especially in complex cases where standard options are limited or exhausted.In the end, you have two paths: you can choose to stop the off-label medications if you feel the concerns are valid and want to stay under your current doctor’s care. Or, if you still believe in this approach and want to continue, you may need to find another oncologist who is more open to working with you through SDM. We will support you either way, and help make sure your care stays coordinated and focused on your goals.

Q: Can I continue with my standard cancer treatments while on the Omega Precision Oncology off-label medicine cocktail?

A: Yes, the Omega Precision Oncology off-label medicine cocktail is intended to be used alongside your standard cancer treatments. It’s important to keep all your healthcare providers informed about every medication and treatment you are using. This helps ensure your care is coordinated and as safe and effective as possible.

Q: Can I just take the Omega Precision Oncology off-label meds without doing standard treatments like chemotherapy or immunotherapy ?

A: We don’t recommend using the Omega off-label medicine cocktail as a substitute for standard cancer treatments. These medications are meant to work alongside treatments like chemotherapy, immunotherapy, or radiation—not replace them. It’s important to stay on your standard care plan unless your oncology team advises otherwise. Using both approaches together may offer the best chance for results.

Q: I’ve finished all my standard cancer treatments. Can I still take the Omega off-label medications?

A: Yes, you can take the Omega Precision Oncology off-label medicine cocktail even if you’ve completed your standard treatments—especially if your oncologist agrees that no further standard care is needed right now. These medications may still help slow down cancer growth or recurrence, even when you’re not on chemotherapy, radiation, or immunotherapy.

Q: I’m doing well on chemotherapy and my oncologist says I’ve had an excellent response. Do I still need extra medicine like the Omega protocol?

A: Yes, even if you’re responding well to chemotherapy, it can still be helpful to consider adding the Omega Precision Oncology off-label medicine cocktail. These are low-toxicity medications that may help target cancer cells in different ways—like interfering with cancer metabolism, inflammation, or resistance pathways. The goal is to strengthen your current treatment and reduce the chance of recurrence by hitting cancer from multiple angles.

Q: I’m on immunotherapy. Should I take the Omega off-label medicine cocktail ?

A: Yes, you can take the Omega Precision Oncology off-label medicine cocktail while on immunotherapy. In fact, some of the medications we use—like hydroxychloroquine—may actually enhance the effects of immunotherapy by modulating immune responses and reducing resistance. However, we usually avoid using doxycycline in patients actively receiving immunotherapy, because it may alter the gut microbiome in a way that could reduce the effectiveness of immunotherapy. Each case is unique, so we would tailor the regimen to best support your current treatment.

Q: I’m participating in a clinical trial. Can I still take the Omega off-label medications ?

A: This can be a bit complicated. From a medical standpoint, it might be reasonable to take the Omega Precision Oncology off-label medicine cocktail while enrolled in a clinical trial—but it really depends on your specific case and the rules of the trial you’re in. Even if we review your records and determine that the off-label medications are medically appropriate and not likely to cause harmful drug interactions, the final decision belongs to the clinical trial doctor or sponsor. Many trials have strict protocols that do not allow any non-standard treatments, including off-label medications like ours.What we can do is check for any potentially harmful interactions between the trial drug and our medications, and flag them if there are concerns. But we cannot recommend that you take our medicines without approval from the clinical trial team, as that could put your participation in the trial at risk .

Q: I’ve already gone through several rounds of chemotherapy, but they didn’t work. My oncologist has stopped treatment and placed me on hospice. Is the Omega protocol still an option for me ?

A: I’m really sorry to hear what you’re going through. Yes, the Omega Precision Oncology off-label medicine cocktail could still be an option. While it’s usually recommended alongside standard cancer treatments, that doesn’t mean it can’t offer benefit on its own. Some patients have chosen to try it even after standard treatments have stopped, hoping to slow cancer progression. If you decide to move forward, we’d suggest monitoring your cancer markers or scans to help guide the next steps.

Q: What is your success rate with the Omega Precision Oncology off-label medicine cocktail ?

A: I don’t have a precise percentage for success rates, and that’s because each patient is different. In real-world practice at Omega, we see patients with many different cancer types and stages, often using this cocktail alongside other treatments. That makes it hard to calculate an exact success rate. Still, I can say that many of our patients have had responses that exceeded expectations—sometimes even surprising their primary oncologists.The key is close monitoring through imaging like CT or PET scans or Signatera. That’s how we track whether the approach is helping. One major advantage is that these medicines are generally well tolerated and much safer than most standard cancer treatments, which is why we believe they’re worth considering for patients looking for more ways to stay in control of their disease.

Q: How soon should I notice the benefits of the off-label medicine? Does it take several days or several months ?

A: Great question. Most of these meds start circulating in your body within a few hours after you take them. But when it comes to actually making a difference against cancer, we’re usually talking at least a month or more. That said, there’s no one-size-fits-all answer. Every cancer behaves differently—some grow fast, others slow—and many patients are also on standard treatments like chemo or immunotherapy at the same time. So it’s really hard to tell exactly when you’ll start feeling a change. For most people, it’s more of a gradual effect over several months rather than something immediate.

Q: How are patients followed up, and how can I make an appointment?

A: Ongoing medical supervision is a key part of what we do at Omega Precision Oncology. Since your health, labs, and standard treatments can change over time, we closely monitor everything and adjust your protocol as needed. Our goal is always to support your overall care.We typically schedule follow-up visits with your physician every 12 weeks. During these appointments, we review your lab results, check on your progress, and make any necessary adjustments to your treatment. In between, you’ll also have check-ins with our cancer care navigator or nursing staff every 1 to 2 months to make sure everything is on track and to flag any issues that may need the doctor’s attention. If you have questions or concerns at any time, you’re welcome to contact us by phone or email—there’s no extra charge for that. Appointments are focused on keeping your treatment safe, effective, and personalized.

Q: Dr. Zhang, thank you. You’ve prescribed quite a few medicines for me, but I’m not someone who usually likes taking medication. I’m worried about side effects and don’t feel comfortable taking all of them. What should I do?

A: That’s a very reasonable concern, and you’re not alone—most people don’t like taking a lot of medications. I want you to know that we take this seriously. We carefully check for drug–drug interactions (DDIs) using advanced databases and medical literature. Your safety is always a top priority, and we include lab monitoring to make sure everything stays on track.That said, if taking all the prescribed medications at once feels overwhelming, that’s perfectly okay. You can start with just a few and slowly build up over time, or stick with the ones you feel most comfortable with. This is all part of shared decision making—we’re here to guide you, not to pressure you. The goal is to find a plan that fits your comfort level while still supporting your treatment.

Q: Dr. Zhang, where should I get the medicines? How long does it take? Do I need to call someone?

A: We work with several pharmacies to handle the off-label medications. Some of these medicines, like mebendazole, need to be specially compounded. For compounded medications, we usually send the prescription to a compounding pharmacy such as CareFirst or Pharmacy Solutions—both are experienced in preparing these types of treatments.For other medicines, we can send them to the local pharmacy of your choice, like CVS or Walgreens. The cost will depend on your insurance plan and the pharmacy’s pricing—we don’t control the prices. One exception is Zypitamag (pitavastatin); because most insurance plans don’t cover it well, we usually send it to Marley Drug, which offers a better cash price.You don’t need to call the pharmacy—they will reach out to you once they’ve received and processed your prescription. Compounding pharmacies may take several days to prepare your medication. For standard prescriptions sent to local pharmacies, it might just take a few hours.If you haven’t heard from the pharmacy or received your medication after a few days, and you’re concerned, feel free to call our clinic—we’ll be happy to check the status for you.

Q: Dr. Zhang, thank you so much for all your insights today. I know it’s been a long conversation, and we’ve covered a lot of ground. Before we wrap up, do you have any final thoughts to leave us with?

A: I’m glad you asked. Let me leave you with something that’s stayed with me for a long time. It comes from one of the oldest and wisest texts—the Bible.In Luke 10:33-34, there’s that familiar story of the Good Samaritan. When he finds the injured traveler, he doesn’t just feel bad for him—he actually steps in to help. And what does he do? He pours on oil and wine.That image has always spoken to me, especially in my role as a physician treating cancer patients. It’s more than just a medical reference from ancient times. There’s deep symbolism there.I think of the oil as integrative medicine. It’s gentle. It nourishes. It supports the body’s own healing ability—kind of like the herbs, supplements, and nutrition plans we use to help our patients recover and stay strong.And then there’s the wine. Wine isn’t gentle—it’s sharp, it kills bacteria, it gets to the root of the problem. That’s chemotherapy. It’s powerful. It’s necessary. But it can also be hard on the body.And here’s the key—he used both. Not just the oil, not just the wine. Because healing, true healing, often needs both. If we only use the oil, we might comfort but never cure.

A: If we only use the wine, we might kill the disease but harm the person in the process. But when we use both together? That’s when things start to shift. That’s when healing can really begin. In my work, I see that all the time. Patients do best when we balance both approaches—integrative support and conventional treatment. It’s not about choosing one or the other. It’s about bringing them together, like the Samaritan did, with compassion, wisdom, and action. So if I had to sum it up—it’s oil and wine. Kindness and strength. Healing and hope. That’s the heart of what I try to do every day.